Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity (unaudited)

v3.20.4
Statements of Stockholders' Equity (unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid - In Capital Shares to Be Issued [Member]
Accumulated Deficit [Member]
Cumulative adjustment upon ASC 842 adoption [Member]
Accumulated Deficit [Member]
Cumulative adjustment upon ASC 842 adoption [Member]
Total
Balance at beginning at Sep. 30, 2019 $ 1,092,266 $ 54,160,836   $ 16,429 $ (55,582,010) $ 16,429 $ (328,908)
Balance at beginning (in shares) at Sep. 30, 2019 1,092,266,844            
Stock based compensation   367,841         367,841
Common stock issued for conversion of convertible note payable and accrued interest $ 17,920 530,471         548,391
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 17,919,455            
Common stock registration costs   (15,398)         (15,398)
Stock Issued to extinguish liability $ 38,423 1,498,506         1,536,929
Stock Issued to extinguish liability (in shares) 38,423,221            
Net Loss         (153,143)   (153,143)
Balance at end at Dec. 31, 2019 $ 1,148,609 56,542,256     (55,718,724)   1,972,141
Balance at end (in shares) at Dec. 31, 2019 1,148,609,520            
Balance at beginning at Sep. 30, 2020 $ 1,250,740 58,728,308 $ 105,000   (57,981,672)   $ 2,102,376
Balance at beginning (in shares) at Sep. 30, 2020 1,250,740,346           1,250,740,346
Common Stock issued in settlement of debt $ 17,500 87,500 $ (105,000)        
Common Stock issued in settlement of debt (in shares) 17,500,000            
Net Loss         (358,489)   $ (358,489)
Balance at end at Dec. 31, 2020 $ 1,268,240 $ 58,815,808     $ 58,340,161   $ 1,743,887
Balance at end (in shares) at Dec. 31, 2020 1,268,240,346           1,268,240,346